학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 7건 | 목록 1~20
Academic Journal
Garcia-Tejedor A; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain. Electronic address: agarciat@bellvitgehospital.cat.; Julià C; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Gynecology. Hospital de Viladecans. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona, Barcelona, Spain.; Ciria J; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain.; Guevara-Peralta R; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain.; Ortega-Expósito C; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain.; Ortega R; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Barcelona, Spain.; Stradella A; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Oncology, Multidisciplinary Breast Cancer Unit,a Institut Català d'Oncología. Barcelona, Spain.; Pérez-Montero H; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Oncologic Radiotherapy. Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología. Barcelona, Spain.; Reyes-Juncan G; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Barcelona, Spain.; Benitez A; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Barcelona, Spain.; Guma A; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Barcelona, Spain.; Azcarate J; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Barcelona, Spain.; Campos M; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain.; Plà MJ; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain.; Martinez E; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Oncologic Radiotherapy. Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología. Barcelona, Spain.; Pernas S; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Oncology, Multidisciplinary Breast Cancer Unit,a Institut Català d'Oncología. Barcelona, Spain.; Ponce J; Department of Gynecology. Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Universitat de Barcelona. Barcelona, Spain; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain.; Falo C; IDIBELL Instituto de Investigación Biomédica de Bellvitge. Barcelona, Spain; Department of Oncology, Multidisciplinary Breast Cancer Unit,a Institut Català d'Oncología. Barcelona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Academic Journal
Fernandez-Gonzalez S; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain. sfernandezg@bellvitgehospital.cat.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Feixa Llarga, s/n, 08907, l'Hospitalet de Llobregat, Spain. sfernandezg@bellvitgehospital.cat.; Falo C; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncologia, Idibell, Barcelona, Spain.; Pla MJ; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain.; Campos M; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain.; Ortega-Exposito C; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain.; Ortega R; Department of Radiology, Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Vicente M; Department of Radiology, Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Petit A; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Bosch-Schips J; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Bajen MT; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Reyes G; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Martínez E; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncologia, Barcelona, Spain.; González-Viguera J; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncologia, Barcelona, Spain.; Peñafiel J; Biostatistics Unit, Institut d'Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Spain.; Stradella A; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncologia, Idibell, Barcelona, Spain.; Pernas S; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncologia, Idibell, Barcelona, Spain.; Ponce J; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain.; Garcia-Tejedor A; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, c/ Feixa Llarga s/n. Hospitalet de Llobregat, CP: 08907, Barcelona, Spain.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
López-Codony V; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain.; de Andrés-Pablo Á; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain.; Ferrando-Díez A; Medical Oncology Department, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital (HGTiP), Badalona, Barcelona, Spain.; Fernández-Montolí ME; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain.; López-Querol M; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Tous S; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Ortega-Expósito C; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain.; Torrejón-Becerra JC; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain.; Pérez Y; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain.; Ferrer-Artola A; Bellvitge Biomedical Research Institute (IDIBELL), Pharmacy Unit, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain.; Sole-Sedeno JM; Department of Obstetrics and Gynaecology, Hospital del Mar-Mar Health Park, Barcelona, Spain.; Grau C; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain.; Rupérez B; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain.; Saumoy M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Sánchez M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Peremiquel-Trillas P; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Bruni L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Alemany L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Bosch FX; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Faculty of Health Sciences, Open University of Catalonia (UOC), Barcelona, Spain.; Pavón MA; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Garcia-Tejedor A; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Ortega-Exposito C; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Salinas S; Rehabilitation Service, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Luzardo-González A; Rehabilitation Service, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Falo C; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Martinez-Pérez E; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Pérez-Montero H; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Soler-Monsó MT; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Bajen MT; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Benitez A; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Ortega R; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Petit A; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Guma A; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Campos M; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Plà MJ; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Pernas S; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Peñafiel J; Biostatistics Unit, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Yeste C; Degree in Biology, Monitoring, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Gil-Gil M; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Guedea F; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Ponce J; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.; Laplana M; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Ortega Expósito C; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain. ortegaexposito@gmail.com.; Falo C; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Pernas S; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Pérez Carton S; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Gil Gil M; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Ortega R; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Pérez Montero H; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Stradella A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Martinez E; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Laplana M; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Salinas S; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Luzardo A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Soler T; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Fernández Montoli ME; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Azcarate J; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Guma A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Petit A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Benitez A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Bajen M; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Reyes Junca JG; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Campos M; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Ruiz R; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Ponce J; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; Pla MJ; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.; García Tejedor A; Bellvitge University Hospital: Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ortega-Exposito, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어